USPTO serial 79248879
MINIT
Reviewed by CopyMark Law Group
Reg. 5809567Status 709
- Filing date
- Status date
- Registration date
- Jul 23, 2019
- Examiner
- NEHMER, JASON ROBERT
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with MINIT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
OXFORD NANOPORE TECHNOLOGIES LIMITED
GB
Other trademarks owned by OXFORD NANOPORE TECHNOLOGIES LIMITED
OXFORD NANOPORE TECHNOLOGIES LIMITED
GB
Other trademarks owned by OXFORD NANOPORE TECHNOLOGIES LIMITED
OXFORD NANOPORE TECHNOLOGIES LIMITED
GB
Other trademarks owned by OXFORD NANOPORE TECHNOLOGIES LIMITED
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Ryan M. Van Olst, Esq.
Ryan M. Van Olst, Esq. Wolf Greenfield & Sacks, P.C.600 Atlantic AvenueBoston, MA 02210UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Electronic sensing apparatus, namely, electronic devices for sensing and detecting analytes in scientific test samples for scientific testing purposes; apparatus and instruments for biological, bacteriological, chemical, biochemical, DNA, RNA, protein, polynucleic acid and molecular analysis, namely, automated instruments for detecting the presence, properties and identity of analytes; portable apparatus and instruments for biological, chemical, biochemical, DNA, RNA, protein, polynucleic acid and molecular analysis, namely, automated instruments for detecting the presence, properties and identity of analytes, comprising cartridges, microarrays, silicon chip based arrays, ASICs (application specific integrated circuits), and networked computer hardware and software for performing and controlling the analysis, and for processing, displaying and storing the information obtained from the analysis for scientific or research purposes; scientific apparatus and instruments for use in DNA, RNA, protein and polynucleic acid sequencing; scientific apparatus for the analysis of polynucleic acid sequences; scientific apparatus and instruments for the analysis of nucleic and polynucleic acids; scientific apparatus and instruments for the analysis of proteins; scientific apparatus and instruments for analysis of genetic information, genomic information and proteomic information; apparatus and instruments for use in laboratory analysis, namely, empty cartridges for test samples, namely, cartridges for use with concentrates and solutions in solid or liquid form samples for scientific or research testing use; scientific apparatus, devices and instruments for synthesising chemical compounds, small molecules, genomes, DNA, RNA or other nucleic acids, oligosaccharides, proteins and peptides; data processing apparatus, devices and instruments; apparatus, devices and instruments for identifying, measuring, analysing, sequencing or synthesising small molecules, genomes, DNA, RNA or other nucleic acids, oligosaccharides, proteins and peptides; portable scientific apparatus, devices and instruments for identifying, measuring, analysing, sequencing or synthesising small molecules, genomes, DNA, RNA or other nucleic acids, oligosaccharides, proteins and peptides; instruments and apparatus for the display of information obtained from scientific equipment; silicon chips; DNA chips; analyte detector chips; biosensor chips; batteries; rechargeable batteries; chargers for batteries; power packs in the nature of rechargeable battery packs; Nanopore sensing devices; Structural parts and fittings for all the aforesaid goods | SECTION 71 - CANCELLED | — |
| 010 | Medical and veterinary apparatus for biological, chemical, biochemical, DNA, RNA, protein and molecular analysis; portable medical and veterinary apparatus for biological, chemical, biochemical, DNA, RNA, protein and molecular analysis; liquid biopsy devices for medical and veterinary use; blood testing apparatus; diagnostic apparatus for medical or veterinary purposes for pregnancy testing, and for detecting pathogenic, infectious, psychiatric, oncogenic, metabolic, genetic, respiratory, genitourinary, digestive, inflammatory, autoimmune, reproductive, hepatic, central nervous system, degenerative and cardiovascular diseases or conditions; portable diagnostic apparatus for medical or veterinary purposes for pregnancy testing, and for detecting pathogenic, infectious, psychiatric, oncogenic, metabolic, genetic, respiratory, genitourinary, digestive, inflammatory, autoimmune, reproductive, hepatic, central nervous system, degenerative and cardiovascular diseases or conditions; Portable diagnostic apparatus for medical or veterinary purposes for detecting pathogenic, infectious, psychiatric, oncogenic, metabolic, genetic, respiratory, genitourinary, digestive, inflammatory, autoimmune, reproductive, hepatic, central nervous system, degenerative and cardiovascular diseases or conditions; portable testing apparatus for medical or veterinary purposes for detecting pathogenic, infectious, psychiatric, oncogenic, metabolic, genetic, respiratory, genitourinary, digestive, inflammatory, autoimmune, reproductive, hepatic, central nervous system, degenerative and cardiovascular diseases or conditions; cartridges for test samples, for medical purposes; reaction units containing chemical reagents, for medical purposes | SECTION 71 - CANCELLED | — |
| 042 | Scientific and technological services and research and design relating thereto, namely, consultation, research and design services relating to automated systems and instruments for direct electrical detection and analysis of molecules for application in the field of genomics, protein analysis, molecular analysis, life sciences, healthcare, security and defence; industrial analysis and research services in the fields of genomics, protein analysis, molecular analysis, life sciences, healthcare, security and defence; scientific research for chemical, biochemical, biological, bacteriological, medical or veterinary purposes; biological, chemical, biochemical, bacteriological, DNA, RNA, protein, polynucleic acid and molecular analysis services; services relating to the synthesis of chemical compounds, small molecules, genomes, DNA, RNA or other nucleic acids, oligosaccharides, proteins and peptides; scientific research for medical or veterinary purposes; genome, DNA, RNA and nucleic acid, oligosaccharide, protein and peptide synthesising services; chemical compound and small molecule synthesising services; DNA and RNA and polynucleic acid sequencing services; protein sequencing services; design and development of instruments and apparatus for biological, chemical, biochemical, DNA, RNA, protein and molecular analysis; laboratory testing services; DNA and polynucleic acid testing services; genome sequencing services; Analysis and evaluation of data, namely, scientific and medical data; overseeing, monitoring and managing scientific and medical experiments and tests; overseeing, monitoring and managing the analysis and evaluation of scientific and medical data; design of scientific experiments; analysis of data generated by scientific and medical experiments and tests; biological, bacteriological, chemical, biochemical, DNA, RNA, protein, polynucleic acid and molecular analysis and evaluation services; DNA and RNA and polynucleic acid and protein sequencing, analysis and evaluation services; genome sequencing services and the analysis and evaluation of data resulting therefrom; provision of reports relating to scientific and medical experiments, the results of scientific and medical experiments and tests, the analysis and evaluation of scientific and medical data, and data generated by scientific and medical experiments and tests; scientific and medical research and development services; technical data analysis and evaluation services; electronic data storage services; application service provider (ASP) services for providing access to computer software applications installed or downloaded onto data processing apparatus, scientific apparatus, medical and veterinary apparatus, mobile phones and handheld mobile digital electronic devices; information, advisory and consultancy services relating to the aforesaid | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by OXFORD NANOPORE TECHNOLOGIES LIMITED
- Other trademarks owned by OXFORD NANOPORE TECHNOLOGIES LIMITED
- Other trademarks owned by OXFORD NANOPORE TECHNOLOGIES LIMITED
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named MINIT
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 6, 2026 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Feb 6, 2026 | C71T | CANCELLED SECTION 71 | — |
| Jul 23, 2024 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Nov 6, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 1, 2019 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Nov 12, 2019 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Nov 12, 2019 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Oct 25, 2019 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 23, 2019 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 23, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 7, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 7, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 3, 2019 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Apr 17, 2019 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 17, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 17, 2019 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Mar 18, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 18, 2019 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 18, 2019 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 18, 2019 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 18, 2019 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 7, 2019 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 7, 2019 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 16, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 26, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 26, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 15, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 15, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 14, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 11, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 11, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 3, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |